Silent spread of mobile colistin resistance gene mcr-9.1 on IncHI2 'superplasmids' in clinical carbapenem-resistant Enterobacterales.


Journal

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
ISSN: 1469-0691
Titre abrégé: Clin Microbiol Infect
Pays: England
ID NLM: 9516420

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 14 12 2020
revised: 13 04 2021
accepted: 16 04 2021
pubmed: 30 4 2021
medline: 13 1 2022
entrez: 29 4 2021
Statut: ppublish

Résumé

mcr-9.1 is a newly described mobile colistin resistance gene. We have noted its presence in multiple species of carbapenem-resistant Enterobacterales (CRE) from our institution. We aimed to determine the clinical features, genomic context and phenotypic impact of mcr-9.1 carriage in a series of patients between 2010 and 2019. We identified 32 patients with mcr-9.1-carrying CRE isolates (mCRE) and collected demographic, antimicrobial exposure and infection data. Whole-genome sequencing (including short and long reads) was performed on 32 isolates. We assessed sequence similarity of mcr-9.1-harbouring plasmids, then compared our findings with plasmids for which sequence data were publicly available. There was no colistin exposure in patients prior to isolation of mCRE. mcr-9.1 was identified on IncHI2 plasmids across four different bacterial species and was co-located with bla Spread of mcr-9.1 in CRE from our institution was driven by IncHI2 'superplasmids', so termed because of their large size and their prolific carriage of resistance determinants. These were also detected in global CRE genomes. Phenotypic colistin resistance was not detected in our isolates but remains to be determined from global mCRE.

Identifiants

pubmed: 33915285
pii: S1198-743X(21)00205-6
doi: 10.1016/j.cmi.2021.04.020
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Carbapenems 0
Colistin Z67X93HJG1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1856.e7-1856.e13

Informations de copyright

Copyright © 2021 Royal College of Surgeons of Edinburgh (Scottish charity number SC005317) and Royal College of Surgeons in Ireland. Published by Elsevier Ltd. All rights reserved.

Auteurs

Nenad Macesic (N)

Department of Infectious Diseases, Central Clinical School, Monash University, Melbourne, Australia; Department of Infectious Diseases, Alfred Health, Melbourne, Australia. Electronic address: nenad.macesic@monash.edu.

Luke V Blakeway (LV)

Department of Infectious Diseases, Central Clinical School, Monash University, Melbourne, Australia; Department of Infectious Diseases, Alfred Health, Melbourne, Australia.

James D Stewart (JD)

Department of Infectious Diseases, Cairns Hospital, Cairns, Australia.

Jane Hawkey (J)

Department of Infectious Diseases, Central Clinical School, Monash University, Melbourne, Australia.

Kelly L Wyres (KL)

Department of Infectious Diseases, Central Clinical School, Monash University, Melbourne, Australia.

Louise M Judd (LM)

Department of Infectious Diseases, Central Clinical School, Monash University, Melbourne, Australia.

Ryan R Wick (RR)

Department of Infectious Diseases, Central Clinical School, Monash University, Melbourne, Australia.

Adam W Jenney (AW)

Department of Infectious Diseases, Central Clinical School, Monash University, Melbourne, Australia; Department of Infectious Diseases, Alfred Health, Melbourne, Australia; Microbiology Unit, Alfred Pathology Service, Alfred Health, Melbourne, Australia.

Kathryn E Holt (KE)

Department of Infectious Diseases, Central Clinical School, Monash University, Melbourne, Australia; The London School of Hygiene and Tropical Medicine, London, United Kingdom.

Anton Y Peleg (AY)

Department of Infectious Diseases, Central Clinical School, Monash University, Melbourne, Australia; Department of Infectious Diseases, Alfred Health, Melbourne, Australia; Infection and Immunity Program, Monash Biomedicine Discovery Institute, Department of Microbiology, Monash University, Clayton, Australia.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation
Biofilms Candida albicans Quorum Sensing Candida glabrata Menthol

Classifications MeSH